Nrf2 regulators

A compound of Formula (I)

• wherein,
• B is —(CH2)2-triazolyl which is unsubstituted or substituted by 1, 2, or 3 substituents independently selected from —C 1-3alkyl, —O—C1-3alkyl, CN, —(CH2)2—O—(CH2)2—OR4 and halo;
• D is —C(O)OH, —C(O)NHSO2CH3, —SO2NHC(O)CH3, 5-(trifluoromethyl)-4H-1,2,4-triazol-2-yl, or tetrazolyl;
• R1 is independently hydrogen, C1-3alkyl, F, or the two R1 groups together with the carbon to which they are attached form a cyclopropyl group;
• R2 is hydrogen, methyl, CF3, or halo;
• R4 is hydrogen or —C1-3alkyl;
• Linker is —CH2—, —CH2—N(cyclopropyl)—CH2—, —CH2—N(CH3)—CH2— or —N(CH3)—CH2—;
• A is tetrahydrobenzoxazepinyl or tetrahydro-pyrido-oxazepinyl, each of which is unsubstituted or substituted by 1, 2, or 3 substituents independently selected from —C1-3alkyl, C3-6spirocycloalkyl, halo, CN, —O—C1-3alkyl, —CH2—O—CH3, and OH;
• and
• X is CH;
• or a pharmaceutically acceptable salt thereof.